Assessing the Interplay between Dyslipidemia and Bone-Related Markers in Postmenopausal Women

Authors

  • Adedeji David Atere Dept of Medical Laboratory Science, Osun State University, Osogbo

DOI:

https://doi.org/10.54548/njps.v39i1.6

Abstract

This study investigates the relationship between bone-related markers and dyslipidemia in postmenopausal women in Owo metropolitan, recognizing the critical role of lipids in physiological functions and the heightened risk of cardiovascular diseases with menopause-induced lipid metabolism changes. A total of 100 subjects were enrolled, including 60 postmenopausal (PMP) women, 20 premenopausal (PRM) women, and 20 reproductive women aged (RWA). Fasting blood samples were collected and analyzed for various parameters using standard laboratory procedures. Statistical analysis revealed significantly elevated levels of Total Cholesterol (TC), HDL-C, and LDL-C in both PMP and PRM subjects compared to the RWA (p<0.05). In contrast, ALP, inorganic phosphate, and uric acid levels were significantly higher in PMP and PRM subjects, while FBS, calcium, and vitamin D levels were lower (p<0.05). Furthermore, inorganic phosphate had a strong positive association with TC, TG, and LDL-C among PMP women. These data emphasize the considerable difference in lipid profiles between premenopausal and postmenopausal women, as well as the higher prevalence of dyslipidemia after menopause.

References

Achie, L. N., Olorunshola, K. V, Igashi, J., & Toryila, J. E. (2021). Assessment of the levels of serum parathyroid hormone in rural postmenopausal women in Zuturung district , Zangon Kataf Local Government Area , Kaduna State , Nigeria . 9(December), 130–137.

Adewole, O. A., Idowu, S. O., Shoga, M. O., Kayode, M. O., & Adelowo, O. O. (2021). Frequency of Osteoporosis in Black Nigerian Women Aged 50 and above with Degenerative Musculoskeletal Diseases and Fractures. West African Journal of Medicine, 38(4), 342–346.

Araujo, L. C. C., Cruz, A. G., Camargo, F. N., Sucupira, F. G., Moreira, G. V, Matos, S. L., Amaral, A. G., Murata, G. M., Carvalho, C. R. O., & Camporez, J. P. (2023). Estradiol Protects Female ApoE KO Mice against Western-Diet-Induced Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences, 24(12). https://doi.org/10.3390/ijms24129845

Atere, A. D., Okpoli, H. C., Uwumarogie, K. A., & Moronkeji, A. I. (2020). Correlation between Anemia and Malaria Infection Severity in Patients with Type 2 Diabetes Mellitus in Nigeria. Althea Medical Journal, 7(4), 170–175. https://doi.org/10.15850/amj.v7n4.2085

Black, D. M., & Rosen, C. J. (2016). Clinical Practice. Postmenopausal Osteoporosis. The New England Journal of Medicine, 374(3), 254–262. https://doi.org/10.1056/NEJMcp1513724

Bristow, S. M., Horne, A. M., Gamble, G. D., Mihov, B., Stewart, A., & Reid, I. R. (2019). Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3576–3584. https://doi.org/10.1210/jc.2019-00111

Faulds, M. H., Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2012). The diversity of sex steroid action: regulation of metabolism by estrogen signaling. The Journal of Endocrinology, 212(1), 3–12. https://doi.org/10.1530/JOE-11-0044

Fernandez, M. L., & Murillo, A. G. (2016). Postmenopausal women have higher HDL and decreased incidence of low HDL than premenopausal women with metabolic syndrome. Healthcare (Switzerland), 4(1). https://doi.org/10.3390/healthcare4010020

Kim, K., Ginsberg, H. N., & Choi, S. H. (2022). New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Diabetes & Metabolism Journal, 46(4), 517–532. https://doi.org/10.4093/dmj.2022.0198

Libby, P., & Theroux, P. (2005). Pathophysiology of coronary artery disease. Circulation, 111(25), 3481–3488. https://doi.org/10.1161/CIRCULATIONAHA.105.537878

Manninen, V., Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992). Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation, 85(1), 37–45. https://doi.org/10.1161/01.cir.85.1.37

Nandhini, R., Nath, B., Gaikwad, H. S., Sharma, M., & Meena, S. (2022). Metabolic Syndrome and Its Components: A Cross-Sectional Analysis of Its Distribution among Pre- and Post-Menopausal Women from Northern India. Journal of Mid-Life Health, 13(4), 310–316. https://doi.org/10.4103/jmh.jmh_38_22

Otsuki, M., Kasayama, S., Morita, S., Asanuma, N., Saito, H., Mukai, M., & Koga, M. (2007). Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause (New York, N.Y.), 14(3 Pt 1), 404–407. https://doi.org/10.1097/01.gme.0000247014.56254.12

Pardhe, B. D., Pathak, S., Bhetwal, A., Ghimire, S., Shakya, S., Khanal, P. R., & Marahatta, S. B. (2017). Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal. International Journal of Women’s Health, 9, 781–788. https://doi.org/10.2147/IJWH.S145191

Romandini, A., Baldassarre, D., Genovese, S., Capri, S., Pompilio, G., Scatigna, M., & Werba, J. P. (2023). Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs. Pharmaceuticals (Basel, Switzerland), 16(2). https://doi.org/10.3390/ph16020176

Sarmento, A. C. A., Costa, A. P. F., Vieira-Baptista, P., Giraldo, P. C., Eleutério, J. J., & Gonçalves, A. K. (2021). Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic. Frontiers in Reproductive Health, 3, 779398. https://doi.org/10.3389/frph.2021.779398

Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R. (2023). Bone Turnover Markers: Basic Biology to Clinical Applications. Endocrine Reviews, 44(3), 417–473. https://doi.org/10.1210/endrev/bnac031

Soares, C. N. (2019). Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window. Medical Clinics of North America, 103(4), 651–667. https://doi.org/10.1016/j.mcna.2019.03.001

Song, M.-K., Park, S. I., & Cho, S. W. (2023). Circulating biomarkers for diagnosis and therapeutic monitoring in bone metastasis. Journal of Bone and Mineral Metabolism, 41(3), 337–344. https://doi.org/10.1007/s00774-022-01396-6

Suresh, M., & Naidu, D. M. (2006). Influence of years since menopause on bone mineral metabolism in South Indian women. Indian Journal of Medical Sciences, 60(5), 190–198.

Downloads

Published

2025-01-14

Issue

Section

Full Length Research Articles

How to Cite

Assessing the Interplay between Dyslipidemia and Bone-Related Markers in Postmenopausal Women. (2025). Nigerian Journal of Physiological Sciences, 39(1), 39-43. https://doi.org/10.54548/njps.v39i1.6